BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

315 related articles for article (PubMed ID: 34092969)

  • 1. Open reading frame 3 protein of hepatitis E virus: Multi-function protein with endless potential.
    Yang YL; Nan YC
    World J Gastroenterol; 2021 May; 27(20):2458-2473. PubMed ID: 34092969
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multifunctional ORF3 protein of hepatitis E virus.
    Li X; Sun X; Pinpin J; Zhao Q; Sun Y
    J Med Virol; 2024 Jun; 96(6):e29691. PubMed ID: 38783788
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vaccine Development against Zoonotic Hepatitis E Virus: Open Questions and Remaining Challenges.
    Nan Y; Wu C; Zhao Q; Sun Y; Zhang YJ; Zhou EM
    Front Microbiol; 2018; 9():266. PubMed ID: 29520257
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Viral ORF3 Protein Is Required for Hepatitis E Virus Apical Release and Efficient Growth in Polarized Hepatocytes and Humanized Mice.
    Sari G; Zhu J; Ambardekar C; Yin X; Boonstra A; Feng Z; Vanwolleghem T
    J Virol; 2021 Nov; 95(23):e0058521. PubMed ID: 34523963
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Hepatitis E Virus Open Reading Frame 2 Protein: Beyond Viral Capsid.
    Zhou Z; Xie Y; Wu C; Nan Y
    Front Microbiol; 2021; 12():739124. PubMed ID: 34690982
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatitis E virus ORF3 protein hijacking thioredoxin domain-containing protein 5 (TXNDC5) for its stability to promote viral particle release.
    Sheng Y; Deng Y; Li X; Ji P; Sun X; Liu B; Zhu J; Zhao J; Nan Y; Zhou E-M; Hiscox JA; Stewart JP; Sun Y; Zhao Q
    J Virol; 2024 Apr; 98(4):e0164923. PubMed ID: 38548704
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficient formation and maintenance of humoral and CD4 T-cell immunity targeting the viral capsid in acute-resolving hepatitis E infection.
    Csernalabics B; Marinescu MS; Maurer L; Kelsch L; Werner J; Baumann K; Zoldan K; Panning M; Reuken P; Bruns T; Bengsch B; Neumann-Haefelin C; Hofmann M; Thimme R; Dao Thi VL; Boettler T
    J Hepatol; 2024 Apr; 80(4):564-575. PubMed ID: 38154741
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Research progress in the etiology of hepatitis type E virus].
    Xiong XY; Liu X; Yin X
    Zhonghua Gan Zang Bing Za Zhi; 2023 May; 31(5):460-465. PubMed ID: 37365020
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Update on hepatitis E virology: Implications for clinical practice.
    Debing Y; Moradpour D; Neyts J; Gouttenoire J
    J Hepatol; 2016 Jul; 65(1):200-212. PubMed ID: 26966047
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Progress in the Production of Virus-Like Particles for Vaccination against Hepatitis E Virus.
    Mazalovska M; Kouokam JC
    Viruses; 2020 Jul; 12(8):. PubMed ID: 32751441
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structural aspects of hepatitis E virus.
    Cancela F; Noceti O; Arbiza J; Mirazo S
    Arch Virol; 2022 Dec; 167(12):2457-2481. PubMed ID: 36098802
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Replacement of the hepatitis E virus ORF3 protein PxxP motif with heterologous late domain motifs affects virus release via interaction with TSG101.
    Kenney SP; Wentworth JL; Heffron CL; Meng XJ
    Virology; 2015 Dec; 486():198-208. PubMed ID: 26457367
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structural and molecular biology of hepatitis E virus.
    Wang B; Meng XJ
    Comput Struct Biotechnol J; 2021; 19():1907-1916. PubMed ID: 33995894
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatitis E Virus Replication.
    LeDesma R; Nimgaonkar I; Ploss A
    Viruses; 2019 Aug; 11(8):. PubMed ID: 31390784
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Morphogenesis of Hepatitis E Virus.
    Liu X; Qi S; Yin X
    Adv Exp Med Biol; 2023; 1417():159-169. PubMed ID: 37223865
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of the Quasi-Enveloped Hepatitis E Virus Particles Released by the Cellular Exosomal Pathway.
    Nagashima S; Takahashi M; Kobayashi T; ; Nishizawa T; Nishiyama T; Primadharsini PP; Okamoto H
    J Virol; 2017 Nov; 91(22):. PubMed ID: 28878075
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction of Hepatitis E Virus Anti-ORF3 Antibodies from Systemic Administration of a Muscle-Specific Adeno-Associated Virus (AAV) Vector.
    Maurer L; El Andari J; Rapti K; Spreyer L; Steinmann E; Grimm D; Dao Thi VL
    Viruses; 2022 Jan; 14(2):. PubMed ID: 35215859
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Culture systems for hepatitis E virus.
    Okamoto H
    J Gastroenterol; 2013 Feb; 48(2):147-58. PubMed ID: 23104469
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ORF3 protein of hepatitis E virus is essential for virion release from infected cells.
    Yamada K; Takahashi M; Hoshino Y; Takahashi H; Ichiyama K; Nagashima S; Tanaka T; Okamoto H
    J Gen Virol; 2009 Aug; 90(Pt 8):1880-1891. PubMed ID: 19339479
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Distinct Entry Mechanisms for Nonenveloped and Quasi-Enveloped Hepatitis E Viruses.
    Yin X; Ambardekar C; Lu Y; Feng Z
    J Virol; 2016 Apr; 90(8):4232-4242. PubMed ID: 26865708
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.